Concepedia

Publication | Open Access

Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes

DOIFull Paper Access

52

Citations

8

References

2012

Year

Sunder Mudaliar, Debra Armstrong, Annie A. Mavian, Robin O'Connor‐Semmes, Patricia K. Mydlow, June Ye, Elizabeth K. Hussey, Derek J. Nunez, Robert R. Henry, Robert L. Dobbins
Diabetes Care

Abstract

RE can be safely administered with insulin in type 1 diabetes and reduces plasma glucose concentrations compared with placebo.

References

YearCitations

Page 1